ペプチドペグ修飾

ペプチドペグ修飾

Peptide drugs have shown great potential in the field of disease diagnosis and treatment due to their high activity, low toxicity and high specificity. しかし, peptide drugs also have some limitations, such as peptides are easily degraded by enzymes in vivo, resulting in a short duration of efficacy and the need for frequent administration, and some peptides may trigger an immune response, affecting the therapeutic efficacy and side effects, and the peptides are poorly water-soluble, which affects his bioavailability. To overcome these challenges, we have successfully developed polyethylene glycol (PEG) modification to significantly improve the pharmacokinetic properties and increase the stability of peptide drugs. pharmacokinetic properties of peptide drugs, improving their stability and bioavailability.


Technological Breakthroughs

  • Controlled modification: A variety of PEG derivatives and linker arms have been developed to precisely control the length, branching structure and linkage of PEG molecules to optimize the modification effect.
  • Multi-functional modification: Combining PEG modification with other modification technologies (例えば. fatty acid modification, glycosylation modification, 等) to provide peptide drugs with more functionalities, such as targeting and slow release.
  • Site-specific modification: Through chemical synthesis, PEG molecules are precisely attached to the specific sites of peptides to avoid affecting their active sites.

技術的な利点

Prolonged half-life: PEG modification can increase the size of peptide molecules, reduce renal filtration, and protect peptides from enzymatic degradation, thus significantly prolonging their half-life.
Reduced immunogenicity: Masking the antigenic epitopes on the surface of the peptide reduces its immunogenicity and minimizes side effects.
Improved solubility: Successfully improved the solubility and bioavailability of peptide drugs.
Enhancement of stability: Successfully improve the thermal and chemical stability of peptide drugs, and extend their storage period.
Application Fields
Peptide PEG modification technology has a wide range of applications in many fields, のような:
Drug development: Used to develop long-lasting, low-toxicity, targeted peptide drugs, such as anti-cancer peptides, antibacterial peptides, analgesic peptides, 等.
Diagnostic reagents: for the development of highly sensitive and specific peptide diagnostic reagents, such as tumor marker detection reagents, virus detection reagents.
Biomaterials: Used to develop biocompatible and functional peptide biomaterials, such as tissue engineering scaffolds and drug delivery systems.

管理者のアバター

アレックス・チャン

ペプチド業界アナリスト & 国際サプライチェーンスペシャリスト ペプチド合成製造の専門研究者, 生化学原料貿易, および世界的な医薬品サプライチェーン. GMPグレードの治療用ペプチドを専門としています, 化粧品ペプチド, カスタムペプチド合成, および国境を越えた市場政策分析.

Alex Zhang は、世界的なペプチド合成技術を専門とする業界の専門アナリストです。, バイオ医薬品原料, および国際生化学貿易. ペプチド製造プロセスにおける豊富な経験, 固相合成技術, 品質管理基準, そして世界市場の動向, 彼は信頼できる業界ニュースを提供することに専念しています, 市場動向分析, 世界的な製薬会社向けのサプライチェーンに関する洞察, 化粧品原料販売業者, 研究所研究機関, および生化学物質の購入者. 彼の主な報道内容には治療用ペプチドが含まれます, 化粧品用活性ペプチド, 研究グレードのペプチド, カスタムCDMO合成サービス, 業界ポリシーの最新情報, 輸出関税の変更, および世界のペプチドサプライヤーの開発動向.

事実確認済み & 編集ガイドライン
レビュー者: 対象分野の専門家
Share this article
検索 ワッツアップ サービス 製品